Atrial fibrillation (AF) is the most common cardiac arrhythmia and the treatment options
include medical treatment and catheter-based or surgical interventions. AF is a major cause …

Introduction The latest STS guidelines recommend concomitant atrial fibrillation (AF)
ablation not only during mitral surgery (Class IA) but also during other‐than‐mitral cardiac …

Objective Surgical ablation of atrial fibrillation (AF) is indicated both in patients with AF
undergoing concomitant cardiac surgery and in those who have not responded to medical …

Objective Preoperative atrial fibrillation (AF) increases risk of stroke, heart failure, and all-
cause mortality after cardiac surgery. Despite encouraging results and guideline …

The number of individuals referred for coronary artery bypass grafting (CABG) with
preoperative atrial fibrillation (AF) is reported to be 8% to 20%. Atrial fibrillation is a known …

Background Benefits of concomitant atrial fibrillation (AF) surgical treatment are well
established. Cardiac societies support treating AF during cardiac surgery with a class I …

Background Societal guidelines support concomitant management of atrial fibrillation (AF) in
patients undergoing cardiac surgery. To assess real-world adoption and outcomes, this …

Surgical ablation is a well-established therapy for patients with atrial fibrillation (AF)
undergoing cardiac surgery. However, it is not clear if this translates to an improvement in …

Untreated atrial fibrillation is associated with an increased risk of all-cause mortality and
morbidity. Despite the current guidelines recommending surgical ablation of atrial fibrillation …

Pulmonary vein isolation (PVI) is a well‐established treatment for atrial fibrillation (AF);
however, studies report suboptimal outcomes in persistent AF. Adjuvant ablation targeting …